Clinical Trial

CT TAVR Abdomen Study

Study acronym: CT TAVR
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
A standard polyenergetic CT (computed tomography) procedure utilizes 100 ml of iodinated contrast. A recent world-wide shortage of iodine based intravenous contrast has highlighted the need to search for alternative methods or doses. Reducing iodinated IV contrast dose can mitigate IV contrast supply shortages and enable significant cost savings for the radiology practice and hospital system. In addition, decreased IV contrast dose can potentially reduce the rate of acute kidney injury, specifically in patients with decreased renal function. The purpose of the study is to determine whether low IV contrast dose CT with monoenergetic reconstruction can be use for presurgical planning of transcatheter valve replacement (TAVR) procedure.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-02-24; most recent amendment 2026-06-29.
Status change: Not Yet Recruiting → Recruiting 2023-12-14
Trial Details
NCT Number NCT05758701
Lead Sponsor University of Maryland, Baltimore
Conditions Transcatheter Aortic Valve Replacement
Enrollment 164 participants
Start Date 2023-09-19
Primary Completion 2028-03-01 (estimated)
Study Completion 2028-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-01